145 related articles for article (PubMed ID: 8330341)
1. DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA.
Fischer WH; Beland PE; Lutz WK
Carcinogenesis; 1993 Jul; 14(7):1285-8. PubMed ID: 8330341
[TBL] [Abstract][Full Text] [Related]
2. Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2'-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[alpha]anthracene.
Fischer WH; Lutz WK
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5900-4. PubMed ID: 7597050
[TBL] [Abstract][Full Text] [Related]
3. Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA.
Fischer WH; Lutz WK
Toxicol Lett; 1998 Sep; 98(1-2):59-69. PubMed ID: 9776562
[TBL] [Abstract][Full Text] [Related]
4. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate.
Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH
Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919
[TBL] [Abstract][Full Text] [Related]
5. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.
Robertson FM; Ross MS; Tober KL; Long BW; Oberyszyn TM
Carcinogenesis; 1996 Aug; 17(8):1719-28. PubMed ID: 8761432
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells.
Huang MT; Ma W; Yen P; Xie JG; Han J; Frenkel K; Grunberger D; Conney AH
Carcinogenesis; 1996 Apr; 17(4):761-5. PubMed ID: 8625488
[TBL] [Abstract][Full Text] [Related]
9. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
10. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
11. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide.
Reiners JJ; Kodari E; Cappel RE; Gilbert HF
Carcinogenesis; 1991 Dec; 12(12):2345-52. PubMed ID: 1747938
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
14. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.
Mills KJ; Bocckino SB; Burns DJ; Loomis CR; Smart RC
Carcinogenesis; 1992 Jul; 13(7):1113-20. PubMed ID: 1638676
[TBL] [Abstract][Full Text] [Related]
15. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
16. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
DiGiovanni J; Sawyer TW; Fisher EP
Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
Birt DF; Pelling JC; Tibbels MG; Schweickert L
Nutr Cancer; 1989; 12(2):161-8. PubMed ID: 2496398
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone (DHEA) and 3 beta-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice.
Pashko LL; Rovito RJ; Williams JR; Sobel EL; Schwartz AG
Carcinogenesis; 1984 Apr; 5(4):463-6. PubMed ID: 6231135
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Kim TW; Smart RC
Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
[TBL] [Abstract][Full Text] [Related]
20. 32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene.
Randerath E; Agrawal HP; Weaver JA; Bordelon CB; Randerath K
Carcinogenesis; 1985 Aug; 6(8):1117-26. PubMed ID: 3926335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
